Duffy Terrence A's Form 4 filing
CME Group Inc.CME · filed Dec 15, 2025
- Accession no.
- 0001628280-25-056950
- Filed
- Dec 15, 2025
- Trade date
- Dec 11, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $6.74M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Duffy Terrence ACIK 0001212809 | Director, Officer (Chairman and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On December 11, 2025, Mr. Duffy sold an aggregate of 25,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $268.66 to $269.66 for 13,809 shares and $269.68 to $270.51 for 11,911 shares. The Company maintains a record of the transaction and copies will be provided upon request.
Referenced by the price of 2 transactions in Table I.